Alimi Hojabr Insider Trades

Insider Trading History

Track insider trading activity for Alimi Hojabr. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pulmatrix
Pulmatrix PULM
CEO And Chief Science Officer
Holding Value $211k 159,500 shares
Last Trade
May 12, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.54M 159,500 shares
$15.92
$1.32
Pulmatrix
Pulmatrix PULM
CEO And Chief Science Officer
Holding Value $165k 125,000 shares
Last Trade
May 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 125,000 shares
$15.75
$1.32
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.25M 1,031,050 shares
Last Trade
Dec 10, 2012 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.2M 5,500 shares
$4,031.37
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.25M 1,031,050 shares
Last Trade
Dec 07, 2012 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.7M 5,300 shares
$4,095.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.23M 1,020,250 shares
Last Trade
Dec 06, 2012 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$36.3M 9,000 shares
$4,032.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $578k 478,070 shares
Last Trade
Jun 07, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.86B 150,000 shares
$12,411.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.22M 1,011,250 shares
Last Trade
Mar 10, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$254M 15,000 shares
$16,947.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $397k 328,070 shares
Last Trade
Mar 09, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171M 15,000 shares
$11,403.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.24M 1,026,250 shares
Last Trade
Mar 09, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171M 15,000 shares
$11,403.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.6M 1,326,250 shares
Last Trade
Aug 10, 2009 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.35B 315,000 shares
$13,797.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.42M 1,176,250 shares
Last Trade
Aug 10, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.35B 315,000 shares
$13,797.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $147k 121,247 shares
Last Trade
Aug 10, 2009 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.35B 315,000 shares
$13,797.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $796k 658,070 shares
Last Trade
Mar 10, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2B 291,000 shares
$6,867.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.22M 1,011,250 shares
Last Trade
Mar 06, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$87.3M 13,200 shares
$6,615.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.24M 1,024,450 shares
Last Trade
Mar 05, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.2M 7,800 shares
$6,690.60
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.25M 1,032,250 shares
Last Trade
Mar 04, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$130M 17,800 shares
$7,308.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.27M 1,050,050 shares
Last Trade
Mar 03, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$46.1M 6,200 shares
$7,434.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.28M 1,056,250 shares
Last Trade
Mar 03, 2009 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$558M 75,000 shares
$7,434.00
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Chief Executive Officer
Holding Value $1.19M 981,250 shares
Last Trade
Mar 07, 2008 Sale (Open Market)Shares sold on the open market or in a private sale.
$512M 15,000 shares
$34,114.50
$1.21
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals SNOA
Ceo, President
Holding Value $1.21M 996,250 shares
Last Trade
Nov 16, 2007 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$391M 12,500 shares
$31,311.00
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up